CRONOS GROUP NASDAQCRON STOCK QUOTE

https://thecronosgroup.com/

LATEST NEWS FROM CRONOS GROUP

Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

Cronos Group Files Form 12b-25

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

Cronos Group Appoints Bob Madore as Chief Financial Officer

Cronos Group Reports 2021 Second Quarter Results

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders

Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company

Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG

Cronos Group Inc. to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021

Cronos Group Launches Marketing Code to Drive Responsibility Within the Cannabis Industry

Cronos Group Reports 2021 First Quarter Results

Cronos Group Inc. to Hold Virtual 2021 Annual Meeting of Shareholders

Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021

Lord Jones™ Debuts “A Higher Order”

Kristen Bell’s Happy Dance™ Available Now at Ulta Beauty™

Cronos Group Reports 2020 Fourth Quarter and Full-Year Results